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Antimicrobial Activity of Extracts from Native Plants of  
Temperate Australia
ABSTRACT
Introduction: Significant effort has been invested in looking at the 
antimicrobial activity of plant extracts from tropical regions of Australia, 
with less interest in those from more temperate environments. We 
sought to redress this imbalance by examining antimicrobial activities of 
extracts from native plants of Victoria. Methods: Sixteen plant samples 
were obtained around the Ballarat region of Victoria. Plant material was 
desiccated, ground and extracted with methanol at room temperature. 
Methanol extracts were subsequently dissolved in water, filtered and 
freeze dried. Extracts were dissolved in water and their activity determined 
against eight bacterial species. Plant extracts that showed appreciable 
antibacterial activity in the initial antimicrobial screen were examined 
further with both their MICs and MBCs determined. Results: Ten of the 
sixteen plant extracts showed antimicrobial activity. Extracts of Eucalyptus, 
Melaleuca, Prostanthera and Westringia were particularly active with 
MICs as low as 0.25 mg/ml against organisms including P. aeruginosa and 
S. aureus. Conclusion: The current study demonstrates the antimicrobial 
activity of plant extracts from temperate Australia. These may serve as 
precursors for future chemotherapy agents.
Key words: Antibacterial Activity, Melaleuca, Prostanthera, Westringia, 
P. aeruginosa.
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INTRODUCTION
The development of antibiotic resistance in pathogenic bacteria is a 
major public health concern.1 The search for alternative antimicrobial 
compounds is an urgent area of biomedical research and extracts derived 
from plants have long held interest as potential sources of new therapeutic 
agents.2 Australian plants have been shown to be a promising source of 
potent antimicrobial agents.3-7
Aboriginal populations have used Australia’s native flora for medicinal 
purposes for thousands of years. However, written records of medical 
applications pertaining to plants are few and where they do exist, focus 
mostly on northern and western indigenous populations;8 with less work 
done on the southern and eastern populations. It is feared that much of 
this tribal knowledge may have been lost from more temperate parts of 
Australia.9,10 The aim of the current research was to demonstrate whether 
plant extracts from temperate regions of Australia showed antibacterial 
activity. The plants selected were:
• Acacia species are prevalent throughout Australia and are very 
important in Aboriginal medicine.11 They have been described as 
having antiseptic properties8 and have been used to treat infected 
eyes.10 They are believed to have been important medicinal plants 
in southern Australia.12
• Eucalyptus species have been used as antiseptics.8 Roots and 
leaves have been boiled and drunk as a cure for colds and have 
been documented as being used in western Victoria.12 Aqueous 
preparations of Eucalyptus kinos have been used to treat wounds 
and eye infections.13
• Hakea species have been shown to have antiseptic properties8 and 
H. eyreana mixed with animal fat has been used as emollient to treat 
burns.14 
• Melaleuca species produce potent antibacterial essential oils15 and 
are used as antiseptics by Aborigines.8
• Prostanthera species have been documented as being used as 
antiseptics in northern Australia.8
• Solanum laciniatum is prolific in the southern temperate regions 
of Australia and New Zealand. Maori, indigenous people of 
New Zealand, used the leaf of S. laciniatum to form poultices to 
treat ulcers.16 It is an important source of solasodine17 and it is very 
plausible it would have been investigated for medicinal purposes by 
Aborigines in this region.
In addition to these plants with known traditional medicinal applica-
tions, we also prepared extracts from the following: Duboisia hopwoodii, 
Hymenosporum flavum, Philotheca myoporoides and Westringia 
fruticosa. With the exception of Duboisia, there is very little documented 
evidence for medicinal application of these plants. They were included 
due to their widespread distribution and accessibility to the native 
population. Duboisia is well known as an important plant among 
pre-contact Aborigines, it was chewed to release nicotine.18 It was 
included in the study due to its importance to indigenous people, rather 
than documented antiseptic use.
Characterisation of the antimicrobial activity of some of these plants 
has been investigated previously.15,19 However, the focus tends to be on 
the essential oils and organic extracts. Essential oils are rich in terpenes, 
which are relatively insoluble in water. The focus of the current manu-
script was to attempt to replicate Aboriginal plant preparations which 
were typically made by infusion, decoction or maceration: Aborigines 
did not use distillates or alcoholic extracts.14 To this effect we used a 
two stage extraction consisting of a methanol extraction followed by an 
aqueous extraction allowing recovery of only the aqueous polar com-
ponents from each plant. Ultimately it is hoped this research initiative 
will yield new compounds to help combat the rise of antibiotic resistant 
bacteria.
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MATERIALS AND METHODS
Plant collection
Sixteen samples of plant material representing ten Australian plant genera 
were investigated. In two instances two variants (based on difference 
in foliage) of the same plant were sampled (Melaleuca alternifolia and 
Prostanthera ovalifolia). Sample types included were: leaves (n=12), fruit 
(n=2), flowers (n=1), and flower buds (n=1). Plant material was collected 
from the Ballarat region of Victoria, Australia, with the exception of the 
Duboisia hopwoodii sample, which was obtained from Nanya Station in 
south-west New South Wales.
Plant extraction
Plant material was dried in a food dehydrator and ground to obtain a 
coarse powder. Five gram portions of dried plant material were exhaus-
tively extracted with 100 mL of analytical methanol (Sigma-Aldrich) 
using a mechanical shaker for 15 h. The methanolic extract was filtered 
using a Whatman filter paper (Whatman No. 4) before concentrating it 
to dryness using a rotary evaporator (water bath temperature 27°C). The 
dried methanol extract was reconstituted with 20–30 mL of water and 
filtered using a Whatman filter paper (Whatman No. 4). The resulting 
aqueous filtrate was frozen at -80°C prior to freeze drying (Christ Alpha 
2-4 LD Plus). The freeze dried residue was kept in a desiccator at 0– 4°C 
until required for bioassays.
Microorganisms
Eight microorganisms were assayed to represent both gram positive and 
negative species: Bacillus subtilis (NCTC 10400), Listeria monocytogenes 
(ATCC 7644), Micrococcus luteus (University of Melbourne culture 
collection), Staphylococcus aureus (NCTC 6571), Escherichia coli (ATCC 
11775), Klebsiella pneumoniae (HAC8), Pseudomonas aeruginosa 
(NCTC 10662) and Salmonella enterica serovar Typhimurium (UQ 723). 
Routine cultivation of these organisms was performed on nutrient agar 
incubated at 37°C under ambient oxygen.
Antibacterial assays
Aqueous extracts were tested for antimicrobial efficacy by broth dilution 
using the EUCAST method.20 Extracts were filter sterilized (0.22 μm) 
and approximately 4 mg/ml of each extract was used for an initial screen. 
Dilutions were performed in Mueller-Hinton (Oxoid, Basingstoke, UK) 
broth and incubated in ambient air at 37°C for 20 h. Antimicrobial activity 
was assessed by visual examination and semi-quantitated by measuring 
absorbance at 600 nm relative to a broth culture with no extract. The 
extracts showing the greatest activity had their MIC/MBC determined 
using a doubling dilution from 0.12–4 mg/ml, again using the EUCAST 
method. Bactericidal activity was determined by applying 10 μl of each 
broth culture to nutrient agar and incubated at 37°C for 48 h.
RESULTS
An initial screen of extract activity was performed on the sixteen 
aqueous extracts. Assays were performed by broth dilution, rather than 
plate-hole or disc diffusion methods commonly employed. The rationale 
for this was to provide a more sensitive assay and one that was aligned 
with clinical methods of antimicrobial susceptibility testing. The extracts 
were assayed for activity at 4 mg/ml against eight different bacteria (Table 
1). Of the 16 extracts six (38%) showed no appreciable antimicrobial ef-
fect, and were not investigated further. 
In general, the extracts had greater activity against Gram positive 
bacteria, particularly M. luteus and S. aureus, which is consistent with 
the findings of other researchers.3,5 The activity against Gram-negative 
bacteria was minimal: none of the extracts showed activity against the 
three Enterobacteriacae species, while three extracts showed some 
activity against P. aeruginosa. Interestingly, there was little difference 
between plant variants of the same species: both M. alternifolia variant 
extracts were active against M. luteus, S. aureus, and P. aeruginosa, 
while both P. ovalifolia variant extracts were active against all the Gram-
positive pathogens. The most potent antimicrobial activities generally 
came from leaf material. A notable exception being S. laciniatum where 
extracts from fruit (particularly ripe fruit) were the most active.
The extracts from four plant species; Eucalyptus spp., M. alternifolia, P. 
ovalifolia and W. fruticosa were particularly potent against certain bacteria 
and in an attempt to quantify this activity, MIC and MBC assays were 
performed against a selected group of particularly susceptible bacteria 
(Table 2). It should be noted that the extraction process employed is 
not specific and crude plant extracts are generally a mixture of active 
and non-active compounds. Crude mixtures will have markedly higher 
MICs than single active compounds and for this reason, an MIC of less 
than 1 mg/ml is interpreted in this study as showing strong antibacterial 
potential. The extracts showed remarkably high potency in this assay. An 
especially striking finding is the activity M. alternifolia and Eucalyptus 
spp. extracts against P. aeruginosa with MICs of 0.25–0.5 mg/ml.
DISCUSSION
Recent decades have seen an increased interest in examining plants 
for potential antimicrobial agents21 driven by the concomitant rise of 
antibiotic resistant bacteria. The ten plants examined herein showed 
a range of antimicrobial activity against the panel of eight bacteria. 
Unsurprisingly, for most of the plants with limited documented 
indigenous usage, in vitro antimicrobial activity was minimal. Conversely, 
however, Westringia fruticosa, a plant with no described medicinal usage 
was potent in in vitro antimicrobial assays. 
The extract of the white sallow wattle (Acacia floribunda) was effective 
against L. monocytogenes, but had little activity against other bacteria. 
This builds on previous studies that found little antimicrobial activity 
from methanolic extracts of eight Acacia species in a disc diffusion assay.22 
However, this study was only performed against two bacterial pathogens: 
S. aureus and S. pyogenes and therefore overlooked the inhibitory effect 
against Listeria. Conversely, Pennacchio et al found methanolic extracts 
of two different Acacia species were active against both S. aureus and 
S. pyogenes.7
There is little published on the antimicrobial activity of Solanum laciniatum 
extracts. Some anti-fungal activity in extracts of S. laciniatum leaves 
against C. albicans has been demonstrated, but no antibacterial activity.23 
This supports our finding–there was little activity in the leaves, but there 
was activity in the fruit, particularly as they ripened.
Extracts from four plant genera were particularly active in the initial 
antimicrobial screen: Eucalyptus spp., M. alternifolia, P. ovalifolia, W. 
fruticosa. To quantity the activity of these extracts, MICs and MBCs were 
determined against selected bacteria. Eucalyptus extracts showed potent 
activity against gram-positive bacteria (although not B. subtilis) and also 
the gram-negative bacteria P. aeruginosa. This matches findings of other 
researchers: aqueous extracts of kinos from 13 Eucalyptus species had 
activity against the gram-positive bacteria S. aureus and B. subtilis,13 
whilst aqueous extracts of E. olida and E. staigerana also showed activity 
against S. aureus (MIC 15.6 μg/ml and 125 μg/ml, respectively) although 
no activity against six other bacteria.3 
The essential oils of M. alternifolia have well documented antibacterial 
activity against a broad spectrum of bacteria15,19,24,25 while the activity 
of aqueous Melaleuca extracts are less well documented. The 
M. alternifolia extracts in the current study were notable for their 
activity against P. aeruginosa (MIC 0.25 mg/ml). Previous studies have 
shown M. alternifolia essential oils have MICs of 1-8% (vol/vol) against 
P. aeruginosa.15 
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Prostanthera species, like many other Australian plants, have been 
shown to have essential oils with potent antimicrobial activity. Essential 
oils from the desert species P. centralis have been shown to be effective 
against gram-positive bacteria with MICs against B. subtilis and S. aureus 
of approximately 0.1 mg/ml26 only two double-dilutions lower than the 
activity of the aqueous extracts in the current report (0.5 mg/ml).
There have been few investigation into the antibacterial activity of 
Westringia species. Cinnamate esters of catepol isolated from W. fruticosa 
were antifungal against Cladosporum,27 but methanolic extracts of 
W. fruticosa (leaves and flowers) were shown not to exhibit an antibacterial 
effect on four bacterial species (including B. subtilis).28 We also found 
activity against B. subtilis was minimal, but the extract was very active 
against the three other gram-positive bacteria examined. This is a novel 
observation: while work has been performed on other rosemary genera29 
there is no previous evidence of antibacterial activity from W. fruticosa 
extracts.
Many researchers have investigated the antimicrobial properties of 
Australian plants, but such studies are often focussed on the essential 
oils15,19 and to a lesser extent methanol extracts.30,31 Studies on aqueous 
extracts have typically shown poor antimicrobial activity compared to 
other solvents.3 While some Aboriginal preparations are made by mixing 
plant material with animal fat14 which could contain non-polar compo-
nents in essential oils, many Aboriginal plant preparations are aqueous, 
involving simple infusion, decoction or maceration procedures. The 
pharmacologically active components in these preparations must there-
fore be water soluble.14 It was decided therefore, that aqueous extracts 
represented the most accurate ethnomedical approach.
The MICs described in the current manuscript are higher than those of 
their corresponding essential oils.15,19,26 However, the aqueous extracts 
would consist of a mixture of non-active components including 
carbohydrates, organic acids, proteins and minerals. It is tempting to 
speculate that active compounds may be present in the extracts bound 
to carbohydrates in the form of glycosides: highly polar compounds 
containing one or more sugar units. Bacterial glycosidases may hydrolyse 
these compounds to yield free sugar and an aglycone component, the 
latter of which, may have enhanced antimicrobial activity. Extracts 
of bergamot peel, for example, were showed increased activity after 
enzymatic deglycosylation to yield the flavenoid agylcones.32
Combating the global increase in antibiotic resistance will inevitably 
require the development of new antimicrobial agents. This study 
highlights the antimicrobial potential of several Australian plants: the 
traditional medicinal knowledge of Australian indigenous people may 
provide options for future antimicrobial therapy.
CONCLUSION
In an era of reduced therapeutic options to treat multidrug resistant 
infections, the current study demonstrates the antimicrobial activity of 
plant extracts from temperate Australia. Plants from southern Australia 
are often overlooked in favour of those from the warmer northern and 
western parts of the country about which there is more indigenous 
medicinal knowledge. However, the extracts tested herein showed potent 
activity against a number of pathogens including P. aeruginosa. These 
extracts may serve as precursors for future chemotherapy agents, either 
alone or as a combination therapy.
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PICTORIAL ABSTRACT
• Compounds derived from plant sources have great potential for use as 
antimicrobial agents.
• Ten of sixteen plant extracts showed antimicrobial activity in a broth dilu-
tion assay.
• Gram positive bacteria were especially susceptible to the extracts.
• Extracts of Eucalyptus, Melaleuca, Prostanthera and Westringia were 
particularly active with MICs as low as 0.25 mg/ml against organisms 
including P. aeruginosa and S. aureus.
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